No Consistent Link Found Between β-Blockers, Psychiatric Outcomes
WEDNESDAY, March 1, 2023 (HealthDay News) — There are no consistent links between β-blockers and psychiatric outcomes, according to a study published online Jan. 31 in PLOS Medicine.Yasmina Molero, Ph.D., from the Karolinska Institutet in Stockholm, …
Learn MoreNonacceptance of Statin Recommendation Common, Especially for Women
TUESDAY, Feb. 28, 2023 (HealthDay News) — For patients at high cardiovascular risk, nonacceptance of a statin therapy recommendation is common, especially among women, according to a study published online Feb. 28 in JAMA Network Open.C. Justin Brown…
Learn MoreBreath Analysis Shows Promise for COVID-19 Detection
TUESDAY, Feb. 28, 2023 (HealthDay News) — Breath analysis seems promising for COVID-19 detection, according to a study published online Feb. 28 in JAMA Network Open.Ruchi Sharma, Ph.D., from the University of Michigan in Ann Arbor, and colleagues exa…
Learn MorePersistent Organ Damage Common One Year After COVID-19
TUESDAY, Feb. 28, 2023 (HealthDay News) — Organ impairment persists in 59 percent of individuals one year after COVID-19, according to a study published online Feb. 14 in Journal of the Royal Society of Medicine.Andrea Dennis, Ph.D., from Perspectum …
Learn MorePrimary Care Intervention Increases Prevention of Alcohol Use Disorder
TUESDAY, Feb. 28, 2023 (HealthDay News) — An intervention increases prevention but not treatment engagement for alcohol use disorder (AUD) in primary care, according to a study published online Feb. 27 in JAMA Internal Medicine.Amy K. Lee, M.P.H., fr…
Learn MoreWorse Care Experiences Reported at For-Profit Hospices
TUESDAY, Feb. 28, 2023 (HealthDay News) — Caregivers of patients receiving hospice care report worse care experiences at for-profit hospices, according to a study published online Feb. 27 in JAMA Internal Medicine.Rebecca Anhang Price, Ph.D., from th…
Learn MoreMost U.S. Adults With T2DM Meet Criteria for GLP-RAs, SGLT2is
TUESDAY, Feb. 28, 2023 (HealthDay News) — Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 1…
Learn MoreAbout One-Third of Incidental Pituitary Microadenomas Grow
TUESDAY, Feb. 28, 2023 (HealthDay News) — For patients with incidental pituitary microadenomas, about two-thirds remain unchanged or decrease in size, with any growth occurring slowly, according to a study published online Feb. 28 in the Annals of In…
Learn MoreEight-Week Bedaquiline-Linezolid Noninferior for TB
TUESDAY, Feb. 28, 2023 (HealthDay News) — A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published online Feb. 20 in the New England Journal of Medicine to coincide with …
Learn MorePlasma D-Dimer Can Diagnose Periprosthetic Joint Infection
TUESDAY, Feb. 28, 2023 (HealthDay News) — Plasma D-dimer is noninferior to C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) for diagnosing periprosthetic joint infection (PJI) among patients undergoing revision hip or knee arthroplas…
Learn More